There were 1,640 press releases posted in the last 24 hours and 414,082 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Personalized Stem Cells Announces Stem Cell Knee Arthritis FDA-Approved Phase 1/2a Clinical Trial Results

TO:
Michael Dale, President/COO
Personalized Stem Cells, Inc
+1 833-772-3557

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image